Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis Therapeutics Drug Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Psoriatic Arthritis Therapeutics Drug Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Psoriatic Arthritis Therapeutics Drug Consumption 2014-2024
        • 2.1.2 Psoriatic Arthritis Therapeutics Drug Consumption CAGR by Region
      • 2.2 Psoriatic Arthritis Therapeutics Drug Segment by Type
        • 2.2.1 NF Inhibitors
        • 2.2.2 Interleukin Inhibitors
        • 2.2.3 PDE4 Inhibitors
        • 2.2.4 Others
      • 2.3 Psoriatic Arthritis Therapeutics Drug Consumption by Type
        • 2.3.1 Global Psoriatic Arthritis Therapeutics Drug Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Type (2014-2019)
      • 2.4 Psoriatic Arthritis Therapeutics Drug Segment by Application
        • 2.4.1 Hospital Pharmacies
        • 2.4.2 Retail Pharmacies
        • 2.4.3 Online Pharmacies
      • 2.5 Psoriatic Arthritis Therapeutics Drug Consumption by Application
        • 2.5.1 Global Psoriatic Arthritis Therapeutics Drug Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Psoriatic Arthritis Therapeutics Drug Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Application (2014-2019)

      3 Global Psoriatic Arthritis Therapeutics Drug by Players

      • 3.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Players
        • 3.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Players (2017-2019)
        • 3.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Players (2017-2019)
      • 3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Players
        • 3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Players (2017-2019)
        • 3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Players (2017-2019)
      • 3.3 Global Psoriatic Arthritis Therapeutics Drug Sale Price by Players
      • 3.4 Global Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Psoriatic Arthritis Therapeutics Drug Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Psoriatic Arthritis Therapeutics Drug by Regions

      • 4.1 Psoriatic Arthritis Therapeutics Drug by Regions
        • 4.1.1 Global Psoriatic Arthritis Therapeutics Drug Consumption by Regions
        • 4.1.2 Global Psoriatic Arthritis Therapeutics Drug Value by Regions
      • 4.2 Americas Psoriatic Arthritis Therapeutics Drug Consumption Growth
      • 4.3 APAC Psoriatic Arthritis Therapeutics Drug Consumption Growth
      • 4.4 Europe Psoriatic Arthritis Therapeutics Drug Consumption Growth
      • 4.5 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption Growth

      5 Americas

      • 5.1 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Countries
        • 5.1.1 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
        • 5.1.2 Americas Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
      • 5.2 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Type
      • 5.3 Americas Psoriatic Arthritis Therapeutics Drug Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Countries
        • 6.1.1 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
        • 6.1.2 APAC Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
      • 6.2 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Type
      • 6.3 APAC Psoriatic Arthritis Therapeutics Drug Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Psoriatic Arthritis Therapeutics Drug by Countries
        • 7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
        • 7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
      • 7.2 Europe Psoriatic Arthritis Therapeutics Drug Consumption by Type
      • 7.3 Europe Psoriatic Arthritis Therapeutics Drug Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug by Countries
        • 8.1.1 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption by Type
      • 8.3 Middle East & Africa Psoriatic Arthritis Therapeutics Drug Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Psoriatic Arthritis Therapeutics Drug Distributors
      • 10.3 Psoriatic Arthritis Therapeutics Drug Customer

      11 Global Psoriatic Arthritis Therapeutics Drug Market Forecast

      • 11.1 Global Psoriatic Arthritis Therapeutics Drug Consumption Forecast (2019-2024)
      • 11.2 Global Psoriatic Arthritis Therapeutics Drug Forecast by Regions
        • 11.2.1 Global Psoriatic Arthritis Therapeutics Drug Forecast by Regions (2019-2024)
        • 11.2.2 Global Psoriatic Arthritis Therapeutics Drug Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Psoriatic Arthritis Therapeutics Drug Forecast by Type
      • 11.8 Global Psoriatic Arthritis Therapeutics Drug Forecast by Application

      12 Key Players Analysis

      • 12.1 AbbVie
        • 12.1.1 Company Details
        • 12.1.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 AbbVie News
      • 12.2 Janssen Biotech
        • 12.2.1 Company Details
        • 12.2.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Janssen Biotech News
      • 12.3 Novartis
        • 12.3.1 Company Details
        • 12.3.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Novartis News
      • 12.4 Amgen
        • 12.4.1 Company Details
        • 12.4.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Amgen News
      • 12.5 CELGENE CORPORATION
        • 12.5.1 Company Details
        • 12.5.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 CELGENE CORPORATION News
      • 12.6 Pfizer
        • 12.6.1 Company Details
        • 12.6.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Pfizer News
      • 12.7 Eli Lilly
        • 12.7.1 Company Details
        • 12.7.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Eli Lilly News
      • 12.8 UCB
        • 12.8.1 Company Details
        • 12.8.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 UCB News
      • 12.9 Biogen
        • 12.9.1 Company Details
        • 12.9.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Biogen News
      • 12.10 Bristol-Myers Squibb
        • 12.10.1 Company Details
        • 12.10.2 Psoriatic Arthritis Therapeutics Drug Product Offered
        • 12.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Bristol-Myers Squibb News

      13 Research Findings and Conclusion

      Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
      Asia Pacific is anticipated to dominate the global market over the forecast period owing to its high demand in the region.

      According to this study, over the next five years the Psoriatic Arthritis Therapeutics Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Psoriatic Arthritis Therapeutics Drug business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis Therapeutics Drug market by product type, application, key manufacturers and key regions and countries.

      This study considers the Psoriatic Arthritis Therapeutics Drug value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      NF Inhibitors
      Interleukin Inhibitors
      PDE4 Inhibitors
      Others
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      AbbVie
      Janssen Biotech
      Novartis
      Amgen
      CELGENE CORPORATION
      Pfizer
      Eli Lilly
      UCB
      Biogen
      Bristol-Myers Squibb

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Psoriatic Arthritis Therapeutics Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Psoriatic Arthritis Therapeutics Drug market by identifying its various subsegments.
      Focuses on the key global Psoriatic Arthritis Therapeutics Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Psoriatic Arthritis Therapeutics Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Psoriatic Arthritis Therapeutics Drug submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now